Source:http://linkedlifedata.com/resource/pubmed/id/16139837
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-4-3
|
pubmed:abstractText |
Upregulation of plasminogen activator inhibitor type 1 (PAI-1) expression is a critical mechanism through which transforming growth factor-beta1 (TGF-beta1) accelerates intimal growth. The aim of this study was to identify signaling pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells (EC) and test interventions for blocking these pathways. We transduced cultured bovine EC with an adenoviral vector containing the PAI-1 promoter fused to a beta-galactosidase reporter gene. We used these cells, along with vectors expressing potential modifiers of TGF-beta1 signaling and pharmacologic antagonists of mitogen-activated protein kinase (MAPK) pathways to identify key mediators of basal and TGF-beta1-regulated PAI-1 expression. Basal activity of the PAI-1 promoter was directly correlated with Ras activation and was blocked by a dominant negative (DN) type I TGF-beta receptor. TGF-beta1-stimulated activity of the PAI-1 promoter did not require Ras activation, and was lessened or eliminated by expression of either DN type I or type II TGF-beta receptors and by inhibition of either of two MAPKs: MEK and p38. Our results suggest unanticipated pathways of TGF-beta1 signaling in EC and point to new strategies to limit TGF-beta1-induced vascular disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase...,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-9150
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
186
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
92-100
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16139837-Adenoviridae,
pubmed-meshheading:16139837-Animals,
pubmed-meshheading:16139837-Cattle,
pubmed-meshheading:16139837-Cells, Cultured,
pubmed-meshheading:16139837-Endothelium, Vascular,
pubmed-meshheading:16139837-Gene Transfer Techniques,
pubmed-meshheading:16139837-Genetic Vectors,
pubmed-meshheading:16139837-Mitogen-Activated Protein Kinase Kinases,
pubmed-meshheading:16139837-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:16139837-Pulmonary Artery,
pubmed-meshheading:16139837-Signal Transduction,
pubmed-meshheading:16139837-Transforming Growth Factor beta,
pubmed-meshheading:16139837-Transforming Growth Factor beta1,
pubmed-meshheading:16139837-Up-Regulation
|
pubmed:year |
2006
|
pubmed:articleTitle |
Identification of intracellular pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells.
|
pubmed:affiliation |
Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, CA 94158, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|